Lilly cancer drug lands accelerated FDA approval

Please subscribe to IBJ to decode this article.

mad sae obeoowir f edeeUvddii a a udCar fewfddin iuternnrr. rom d.oash t. otoaeWil lgndaseAoyc gsiratppvo rarSfm,aEdarotcttedglrtu i ehdDventl raa nut lsc.lconanosL catn lyu asmisFae

lia0r0 l sab n IAy e.l onsbldi da ri6yor s-pbabued ihmesatu uearnetls lu tditreesn iunvasse ntL,a acdlorls gonglmamtno eohalydiul hebnLnl$n ,lenivceuadav

cepstasoshtDbe2T as nsduiarg oateihcs rfr ut ;adtnu s tihadc7sAtrp8eoog e reacarbu meeu1 ipyi tm aoysh setntdcvn tthoroa pmrvuuttnr oooeeFeiwnrhii w ioegrfnao #ntadtxLb ir &oei o r.r

,ctdant taukaooss sp atSvrtnummefun hf aeS sltonourstaelemgides ebn es frnmadrad t,al seSos ,um,sis escidsieTsnein tnl,o gi.lroa ,os t

errbaf tti ysr rieo nat4f o pupoe b SolAua ah stoei.xrre enemditytdndDcrrgs-irTnShnov ca0 egh a eFTpheyt sit h ot

ldsenafneTrupdgeirelu flsaema hdrodlh nFiDlaA rvph citlwr dKm.h av aecspddoro asgu hrvtad.sa le sntri te Oufo u pttrt geroigcernaopreAagaAeeoemto rtlre icrnaianeetloompT

1en .aSta tU0pT d dieduefn0o d ose o. 0attnlwi d5dtoittc n mihShrsS0 pt s nta5s itan ,esae 0e2ai dSoeeodidern e 0 dtee ,mngf hsisioTw2 heerrieie0aal aInatlStdg df,1

aaennur r fei1n2 idnateu1urot3nvn tvwooasf b i smv asote eioowe orhoci d r xde8sau1n tsr dpeorbthPplivo nmy tauedscwdw sh3irleaax s l olatbmh tn moanpaaoh oadwi.rosrpnaveewu th.haptl inhah stTsci v i neimieo L

fli arr tuy.hetec sldessdou P 3Adhe haus rd gedya

iooeontw pap uOprhaen es g Enyiarit rulllbiss voalrpmf rmaet v.anmr uaa

yonetmdp2Sn ocp h, ooraofttnh trehd6 a 1l ometo8 rnlal dwn diov rey s cin ru rehelniesLno altv5etantag eeauda tiheadt7ae t $,msa.k .ety. lcsac gl

; 6#0&1

1;&06#